UPDATE: SVB Leerink On Crinetics Pharma: Firm Believes Phase 1 Single Ascending Dose and Multiple Ascending Dose Healthy Volunteer Data For Cushing's Disease 'Could Meaningfully De-Risk The Pipeline'